The Use of VMAT2 Inhibitors for Tardive Dyskinesia. Alabaku O, Olfson M, Stroup TS, Gerhard T, et al. J Clin Psychopharmacol 2026;46:189-194.

Read + Share

Amedeo Smart

Independent Medical Education

Alabaku O, Olfson M, Stroup TS, Gerhard T, et al. The Use of VMAT2 Inhibitors for Tardive Dyskinesia. J Clin Psychopharmacol 2026;46:189-194.
PMID: 41626799